CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
We are very excited to launch our new website! Please take a few moments to click around and explore...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...